
Australian researchers are in the process of developing a detergent that would be able to rinse away its own soap suds.
The new surfactant, which is based on a protein, is called a pepfactant and it binds to DNA to initiate gene expression. As a laundry detergent, the pepfactant can generate suds that can collapse as quickly as they are created.
Advertisement
When the researchers tweaked its amino acid composition, they found they could switch its properties on and off, in response to changing acidity or the presence of zinc ions.
Researchers say that the system would be better for the environment than standard detergents because it is made of amino acids that microbes can attack and destroy.
But a pepfactant detergent will cost much more than conventional petrochemical-based detergents, although the rising cost of oil may change this.
As far as its medical usage is concerned, a pepfactant could be used to help deliver the anticancer drug, Taxol (paclitaxel), with fewer side-effects. Currently the drug, which is an oily substance, is injected into patients along with petrochemicals to help its delivery via the patient's water-based bloodstream.
The research is funded by the Australian Research Council and the researchers have signed a number of commercial agreements with major multinational pharmaceutical and chemical companies.
The work was presented at an American Chemical Society meeting in Boston recently
Source: ANI
LIN/C
Advertisement
But a pepfactant detergent will cost much more than conventional petrochemical-based detergents, although the rising cost of oil may change this.
As far as its medical usage is concerned, a pepfactant could be used to help deliver the anticancer drug, Taxol (paclitaxel), with fewer side-effects. Currently the drug, which is an oily substance, is injected into patients along with petrochemicals to help its delivery via the patient's water-based bloodstream.
The research is funded by the Australian Research Council and the researchers have signed a number of commercial agreements with major multinational pharmaceutical and chemical companies.
The work was presented at an American Chemical Society meeting in Boston recently
Source: ANI
LIN/C
Advertisement
Advertisement
|
Advertisement
Latest Research News

Memory deficits in individuals with epilepsy, especially cognitive difficulties, might partially stem from the transient impairments caused by these slow waves.

High altitude training exhibits potential benefits for pre-surgery patients, enhancing readiness, stated a new study.

The AI method shows promise in identifying imaging biomarkers for diagnosing ADHD.

Diagnosed autistic individuals showed increased premature mortality in the UK, highlighting urgent needs to address associated inequalities.

Study reveals a correlation between hearing impairment and distinct brain region variances, contributing to dementia.